{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:28:49Z","timestamp":1765499329781,"version":"3.48.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772160"],"award-info":[{"award-number":["81772160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jdcr.2024.02.018","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T22:07:26Z","timestamp":1709590046000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report"],"prefix":"10.1016","volume":"64","author":[{"given":"Qiuyu","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10275","key":"10.1016\/j.jdcr.2024.02.018_bib1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jdcr.2024.02.018_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40272-021-00476-w","article-title":"Secukinumab: a review in moderate to severe pediatric plaque psoriasis","volume":"23","author":"Blair","year":"2021","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jdcr.2024.02.018_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molimm.2021.02.011","article-title":"Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis","volume":"133","author":"Chen","year":"2021","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jdcr.2024.02.018_bib4","first-page":"93","article-title":"Erythrodermic psoriasis: pathophysiology and current treatment perspectives","volume":"6","author":"Singh","year":"2016","journal-title":"Psoriasis (Auckl)"},{"issue":"7","key":"10.1016\/j.jdcr.2024.02.018_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamadermatol.2015.2","article-title":"Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis","volume":"151","author":"Moy","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jdcr.2024.02.018_bib6","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/CCID.S407813","article-title":"Biologics for the management of erythrodermic psoriasis: an updated review","volume":"16","author":"Potestio","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jdcr.2024.02.018_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.critrevonc.2016.01.012","article-title":"Thymoma and thymic carcinomas","volume":"99","author":"Scorsetti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.jdcr.2024.02.018_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1346-8138.12456","article-title":"Three cases of psoriasis vulgaris associated with myasthenia gravis","volume":"41","author":"Takahashi","year":"2014","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2024.02.018_bib9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"Alvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.02.018_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2249.2011.04472.x","article-title":"Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course","volume":"166","author":"Hanafusa","year":"2011","journal-title":"Clin Exp Immunol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:23:46Z","timestamp":1765499026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":10,"alternative-id":["S2352512624000730"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.018","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}